Hydroxychloroquine is under clinical development by PureIMS and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Using nasal swabs to identify a child’s asthma subtype may lead to more precise medication prescribing and development of ...

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children and infants.

It’s smart to be as ready as you can be for whatever life throws at you, especially when it comes to your family’s healt ...

Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England, which develops inhaled medicines and ...

KOLs interviewed by GlobalData stressed the lack of biologic therapies specifically targeting T2-low asthma.

Eve doesn't just bring fireworks, parties and resolutions -- it also brings hundreds of new Illinois laws for 2025, with at ...

INR:8656. ancient egypt timeline [Breaking News] Kelun's first inhaler is here! The 20 billion market is rapidly heating up Prostate cancer hormone therapy ...

Market, valued at approximately USD 110.30 million in 2022, is projected to grow at a CAGR of over 6.5% from 2023 to 2030. This market focuses on the production, distribution, and utilization of ...

On December 20, 2024, the U.S. Court of Appeals for the Federal Circuit issued a significant ruling in the Teva v.

The US Court of Appeals for the Federal Circuit on Friday affirmed a lower district court order against Israeli ...